GGrantIndex
← Search

Cooperative Multicenter Network of Neontal Intensive Care Units

$74,808U10FY2012HDNIH

Wayne State University, Detroit MI

Investigators

Linked publications, trials & patents

Paper 38416515Paper 37726016Paper 37640232Paper 36732048Paper 35850744Paper 35850743Paper 35835616Paper 35715492Paper 35301420Paper 35296895Paper 35034096Paper 34999716Paper 34862339Paper 34743364Paper 33986149Paper 33402707Paper 33038899Paper 33024258Paper 32978526Paper 32474029Paper 32111975Paper 31880687Paper 31691959Paper 31431654Paper 31312035Paper 31229956Paper 30961990Paper 30738658Paper 30737489Paper 30641105Paper 30631138Paper 30337189Paper 30062831Paper 29945955Paper 29872859Paper 29795315Paper 29793869Paper 29702710Paper 29666163Paper 29654994Paper 29538362Paper 29398046Paper 29360264Paper 29306493Paper 29246358Paper 28982710Paper 28880260Paper 28697406Paper 28672318Paper 28647272Paper 28600154Trial NCT01954082Trial NCT01954056Trial NCT01793129Trial NCT01793116Trial NCT01534481Trial NCT01467076Trial NCT01353313Trial NCT01223287Trial NCT01223261Trial NCT01203514Trial NCT01203501Trial NCT01203488Trial NCT01203475Trial NCT01203449Trial NCT01203436Trial NCT01203423Trial NCT01203410Trial NCT01203358Trial NCT01203345Trial NCT01193270Trial NCT01192776Trial NCT01035697Trial NCT01030575Trial NCT01029353Trial NCT00882284Trial NCT00874393Trial NCT00874367Trial NCT00873847Trial NCT00614744Trial NCT00598429Trial NCT00349726Trial NCT00273325Trial NCT00233324Trial NCT00114543Trial NCT00109525Trial NCT00067613Trial NCT00063063Trial NCT00059540Trial NCT00016523Trial NCT00011362Trial NCT00009646Trial NCT00009633Trial NCT00009620Trial NCT00005777Trial NCT00005776Trial NCT00005775Trial NCT00005774Trial NCT00005773Trial NCT00005772

Abstract

DESCRIPTION (provided by applicant): The Wayne State University School of Medicine (WSU) is submitting an application for renewal in the NICHD Multicenter Neonatal Research Network (NRN) with the objective of improving the health of high risk infants. The Specific Alms of the WSU site are the following: Specific Aim 1: conduct randomized controlled trials (RCT) to improve the care of high risk infants. Specific Aim 2: perform observational studies and long term follow-up to assess outcome of high risk infants and Specific Aim 3: To disseminate results of research in order to facilitate the development and practice of evidence based medicine. WSU has taken the lead with the PI, Seetha Shankaran, as the Network Study PI in the upcoming NRN trial: Optimizing Cooling as Neuroprotection for Term Infants with Hypoxic-Ischemic Encephalopathy with study training conducted by the WSU team in May 2010. WSU Alternate PI, Dr. Beena Sood, has taken the lead in the study evaluating Inhaled Prostaglandin El for Neonatal Hypoxic Respiratory Failure. This study is pending FDA approval. Based on WSU experience with evaluating brain injury in ELBW infants, WSU site Follow-UP PI, Dr. Athina Pappas has submitted a concept protocol in this application on Erythropoietin as Neuroprotection for Neonatal Intracranial Hemorrhage among ELBW Infants. Dr Shankaran will continue to encourage WSU site personnel to submit protocols to the NRN. Dr Pappas plans to evaluate the role of anesthesia and surgery in contributing to the outcome of ELBW infants participating in the ongoing NRN RCT of Laparotomy versus Drain for Necrotizing Enterocolitis or Isolated Intestinal Perforations and Dr. Sood will examine mesenteric blood flow using the innovative technique of near-infra red spectroscopy (NIRS) among trial participants. The WSU site developed Guidelines for Whole Body Hypothermia for Neonatal HIE; these are available on the public website of the NRN. The WSU team will continue to publish NRN studies and present data at scientific meetings. WSU added a satellite site at the University of Michigan (UM) in May 2010. The WSU site has an Inborn service at Hutzel Women's Hospital (5500 births, 55 bed NICU) and an outborn service at Children's Hospital of Michigan (35 bed NICU). The UM site has 3700 births and a 40 bed NICU. WSU has the goal to include Spectrum Health in Grand Rapids Ml as an additional satellite site in the coming year so that results of trials and observational studies can be disseminated on an on-going manner throughout the state. PUBLIC HEALTH RELEVANCE (See instructions): The WSU site will perform the WSU led RCT and Observational studies noted under the Project Summary and participate in all Network Studies so that the care of high risk neonates can be enhanced, and the mortality rate and rate of neurodevelopmental and cognitive impairments can be reduced. The public heath impact will be a reduction of psychosocial and medical costs to families and society.

View original record on NIH RePORTER →